FDA classifies endoscopic suturing device for weight loss as Class II
/ 1 min read
Table of Contents
The Food and Drug Administration has officially classified a specific type of medical device used for weight loss surgery into Class II. This classification covers endoscopic suturing devices that alter gastric anatomy to restrict stomach volume. The agency determined that these devices can be safe and effective if they meet certain special controls.
Why it matters: This action clarifies the regulatory path for companies making endoscopic suturing tools for weight loss. It balances patient safety by requiring performance testing and proper labeling with a desire to encourage innovation in non-surgical weight loss treatments. The practical effect is that these devices may become more widely available sooner, though patients should still expect them to undergo standard safety reviews before sale.
Who it affects
- Manufacturers of endoscopic suturing systems for gastric restriction
This summary is based on a final order published by the Food and Drug Administration in the Federal Register; readers should consult the original document for full legal text and specific regulatory requirements.
Agency: Health and Human Services Department, Food and Drug Administration
Source: Federal Register — read the official document